Close Menu

NEW YORK ─ Molecular diagnostics firm Progenity said on Monday that it plans to offer $25 million of shares of its common stock in a public offering and $75 million of convertible senior notes in a separate private offering.

The San Diego-based firm is granting the underwriters of the public offering a 30-day option to purchase up to an additional $3.75 million common shares at the public offering price. Piper Sandler and Wells Fargo Securities are joint book-running managers and BTIG is the lead manager for the offering of common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.